Taking the matter further, the Indian government called for an emergency committee meeting yesterday which was attended by senior pharma experts to scrutinize a report made by the World Health Organization. As per the report, Indian cough syrups could potentially be linked to acute kidney injury in children and 66 deaths in the small West African nation of The Gambia.
When the matter got attention last week, a basic inspection was conducted and as per the preliminary report findings, there were several discrepancies found at the facility in relation to the cough syrups. The problem existed in the quality tests of propylene glycol for diethylene glycol and ethylene glycol.
Looking at the seriousness of the matter, the Centre formed an expert committee on 12th October 2022 to analyze the report diligently which was shared by the World Health Organization, and also discuss the further course of action.
The production has been completely halted and the State health minister Anil Vij has issued a notice to the company for its negligence of quality tests.
As Soon as WHO warned about the news of kids dying in Gambia due to the cough syrup made by a local manufacturer, the production of these cough syrups was halted and the investigation began to get clarity on the loophole.
The President of The Gambia Adama Barrow is actively looking into the whole scheme of things and is ensuring the authorities leave no stone unturned in their investigation.
